» Articles » PMID: 30591091

Comparison of Reproductive Function in Female Transgenic and Wildtype C57BL/6 Mice

Overview
Journal Comp Med
Specialty General Medicine
Date 2018 Dec 29
PMID 30591091
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Transgenic (TAg) mice express the oncogenic virus SV40 in Mullerian epithelial cells. Female TAg mice spontaneously develop epithelial ovarian carcinoma, the most common type of ovarian cancer in women. Female TAg mice are infertile, but the reason has not been determined. We therefore investigated whether female TAg mice undergo puberty, demonstrate follicular development, maintain regular cycles, and ovulate. Ovarian cancers in women commonly develop after menopause. The occupational chemical 4-vinylcyclohexene diepoxide (VCD) accelerates follicle degeneration in the ovaries of rats and mice, causing early ovarian failure. We therefore used VCD dosing of mice to develop an animal model for menopause. The purpose of this study was to characterize reproductive parameters in female TAg mice and to investigate whether the onset of ovarian failure due VCD dosing differed between female TAg and WT C57BL/6 mice. As in WT female mice, TAg female mice underwent puberty (vaginal opening) and developed cyclicity in patterns that were similar between the groups. Vehicle-only TAg mice had fewer ovulations (numbers of corpora lutea) than WT animals. VCD exposure delayed the onset of puberty (day of first estrus) in TAg as compared with WT mice. Morphologic evaluation of ovaries revealed many more degenerating follicles in TAg mice than WT mice, and more VCD-dosed TAg mice were in ovarian failure than VCD-dosed WT mice. These results suggest that despite showing similar onset of sexual maturation, TAg mice have increased follicular degeneration and fewer ovulations than WT. These features may contribute to the inability of female TAg mice to reproduce.

Citing Articles

A mouse model mimicking gender-affirming treatment with pubertal suppression followed by testosterone in transmasculine youth.

Dela Cruz C, Kinnear H, Hashim P, Wandoff A, Nimmagadda L, Chang F Hum Reprod. 2022; 38(2):256-265.

PMID: 36484619 PMC: 10167862. DOI: 10.1093/humrep/deac257.


Quantification of multiphoton and fluorescence images of reproductive tissues from a mouse ovarian cancer model shows promise for early disease detection.

Sawyer T, Koevary J, Rice F, Howard C, Austin O, Connolly D J Biomed Opt. 2019; 24(9):1-16.

PMID: 31571434 PMC: 6768507. DOI: 10.1117/1.JBO.24.9.096010.

References
1.
Gaytan F, Morales C, Leon S, Heras V, Barroso A, Avendano M . Development and validation of a method for precise dating of female puberty in laboratory rodents: The puberty ovarian maturation score (Pub-Score). Sci Rep. 2017; 7:46381. PMC: 5388887. DOI: 10.1038/srep46381. View

2.
Connolly D, Bao R, Nikitin A, Stephens K, Poole T, Hua X . Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 2003; 63(6):1389-97. View

3.
Schuler S, Ponnath M, Engel J, Ortmann O . Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet. 2013; 287(6):1187-204. DOI: 10.1007/s00404-013-2784-1. View

4.
Hensley H, Quinn B, Wolf R, Litwin S, Mabuchi S, Williams S . Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. Cancer Biol Ther. 2007; 6(11):1717-25. DOI: 10.4161/cbt.6.11.4830. View

5.
Devine P, Sipes I, Skinner M, Hoyer P . Characterization of a rat in vitro ovarian culture system to study the ovarian toxicant 4-vinylcyclohexene diepoxide. Toxicol Appl Pharmacol. 2002; 184(2):107-15. View